Synthesis and evaluation of a series of novel asymmetrical curcumin analogs for the treatment of inflammation.

Abstract

Curcumin has been reported to possess multiple bioactivities, such as antioxidant, anticancer, and anti-inflammatory properties, however the clinical application of curcumin has been significantly limited by its instability and poor metabolism. Modification of curcumin has led to discovery and development of lots of novel therapeutic candidates. In recent years acute and chronic inflammation has been the focus of numerous studies in various diseases. Here, we synthesized a series of asymmetrical curcumin analogs with high in vitro chemical stability, and their anti-inflammatory activity was evaluated in LPS-stimulated macrophages. According to the bio-screening results and QSAR analysis, these analogs exhibited potent activities against LPS-induced TNF-α and IL-6 release. Among the analogs of the potent anti-inflammatory activity, compounds 3b8 and 3b9 exhibited significant protection and possess enhanced anti-inflammatory activity thereby attenuated the LPS-induced septic death in mice.

DOI: 10.3390/molecules19067287

Extracted Key Phrases

7 Figures and Tables

Cite this paper

@article{Zhang2014SynthesisAE, title={Synthesis and evaluation of a series of novel asymmetrical curcumin analogs for the treatment of inflammation.}, author={Yali Zhang and Leping Zhao and Jianzhang Wu and Xin Jiang and Lili Dong and Fengli Xu and Peng Zou and Yuanrong Dai and Xiaoou Shan and Shulin Yang and Guang Liang}, journal={Molecules}, year={2014}, volume={19 6}, pages={7287-307} }